Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | CASP2 | P42575 | 1/20 | 0.36 |
| ▸ | ALB | P02768 | 3/20 | 0.36 |
| ▸ | ADRB2 | P07550 | 5/20 | 0.35 |
| ▸ | ADRB1 | P08588 | 5/20 | 0.35 |
| ▸ | NAAA | Q02083 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21913856 | 0.90 | ALDH1A1 (0.43) | ALDH1A1CASP2ALBNAAAMEN1 | |
| SCHEMBL25129549 | 0.89 | NOD1 (0.39) | ALDH1A1CASP2ALBADRB2ADRB1 | |
| SCHEMBL14952664 | 0.87 | ALDH1A1 (0.41) | ALDH1A1CASP2ALBNAAAMEN1 | |
| SCHEMBL16409459 | 0.87 | CASP2 (0.51) | ALDH1A1CASP2ALBNAAAMEN1 | |
| SCHEMBL11956479 | 0.86 | KDM4E (0.35) | ALDH1A1 | |
| SCHEMBL17662433 | 0.86 | KDM4E (0.35) | ALDH1A1 | |
| SCHEMBL16248631 | 0.86 | KDM4E (0.35) | ALDH1A1 | |
| SCHEMBL16231545 | 0.86 | FOLH1 (0.42) | ALDH1A1CASP2ALBNAAAFOLH1 | |
| SCHEMBL23944184 | 0.86 | ALDH1A1 (0.40) | ALDH1A1CASP2ALBNAAAMEN1 | |
| SCHEMBL20729996 | 0.86 | ALB (0.38) | ALDH1A1CASP2ALBADRB2ADRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023057814-A1 | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR THE TREATMENT, PREVENTION, OR MANAGEMENT OF HYPERPROLIFERATIVE DISORDERS | VINCERX PHARMA GMBH (DE) | 2023-04-13 | — | — | WO | disclosed |
| WO-2023057813-A1 | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR THE TREATMENT, PREVENTION, OR MANAGEMENT OF HYPERPROLIFERATIVE DISORDERS | VINCERX PHARMA GMBH (DE) | 2023-04-13 | — | — | WO | disclosed |